News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for November 2025 Caitlin E. Cox December 01, 2025
News Daily News Cardiac Fibrosis Linked to Ventricular Arrhythmia in Fit Male Athletes: VENTOUX Michael O'Riordan July 18, 2025
News Daily News Catheter Ablation for AF: Fewer Strokes, Deaths, and HF Hospitalizations L.A. McKeown July 08, 2025
News Conference News HRS 2025 Pairing CIED Lead Extraction With Tricuspid Interventions Appears Safe Todd Neale April 28, 2025
News Daily News AHA Stats Show CV Health of Americans Remains Dire Michael O'Riordan January 28, 2025
News Daily News Age Cutoffs for PFO Closure Deserve a Rethink, Researchers Urge L.A. McKeown October 15, 2024
News Daily News Low CV Risk With ‘Living’ Cancer Therapies, Meta-analysis Shows L.A. McKeown October 09, 2024
News Conference News EHRA 2024 Should Conduction-System Pacing Be Top Choice for CRT? Todd Neale April 15, 2024
News Conference News AHA 2023 Large Study Affirms Safety of Pulsed-Field Ablation, Reveals Some Rare Complications Todd Neale November 13, 2023
News Daily News Nonindicated Atrial Lead for Primary Prevention ICDs Linked to Complications Shelley Wood August 04, 2023
News Daily News Borderline Cost-effectiveness for SGLT2 Inhibitors in HFpEF Todd Neale March 15, 2023
News Daily News Direct Delivery of Antibiotics to CV Device Pocket Infections Appears Promising Todd Neale January 09, 2023
News Daily News CVD Claimed 20 Million Lives in 2021, but Disease Burden Varies Globally Michael O'Riordan December 14, 2022
News Daily News Many ESC Guideline Recommendations Out of Reach in Poorer Regions Michael O'Riordan November 29, 2022
News Daily News mRNA Vaccine-Linked Myocarditis Resolves in Time, Without Clinical Events Michael O'Riordan September 26, 2022
News Daily News ‘Stunning’ Cost Variability Across Centers for Common Cardiac Tests, Procedures Michael O'Riordan July 21, 2022
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for January 2022 Shelley Wood January 31, 2022
News Daily News Apixaban Appears Safer, More Effective Than Rivaroxaban in Medicare Study Todd Neale December 27, 2021